Ascend Wellness Holdings, Inc.
AI Valuation
AI-generated fair value estimate for this company.
AI Fair Value
$0.60
Market Price
$0.50
Undervalued By
16.5%
Method: 10-year two-stage FCF DCF: $32.76M TTM FCF base; 12% growth years 1-5; 5% years 6-10; 11% discount rate; 3% terminal growth; $526.2M net debt; 202.20M Class A shares outstanding.
Reasoning: Ascend is a free-cash-flow-positive multi-state cannabis operator benefiting from maturing state-legal markets and potential federal rescheduling, which would reduce its onerous 280E tax burden; growth assumptions reflect continued market maturation while the discount rate and large net-debt deduction reflect federal illegality, regulatory and leverage risk.